Merlini G - Search Results

1

Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA. Merlini G, et al. Expert Rev Hematol. 2014 Feb;7(1):143-56. doi: 10.1586/17474086.2014.858594. Epub 2013 Dec 18. Expert Rev Hematol. 2014. PMID: 24350907 Review.

2

Treatment of primary amyloidosis.

Merlini G. Merlini G. Semin Hematol. 1995 Jan;32(1):60-79. Semin Hematol. 1995. PMID: 7878479 Review. No abstract available.

3

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

Gertz MA, Lacy MQ, Dispenzieri A, Cheson BD, Barlogie B, Kyle RA, Palladini G, Geyer SM, Merlini G. Gertz MA, et al. Among authors: merlini g. Amyloid. 2002 Mar;9(1):24-30. doi: 10.3109/13506120209072441. Amyloid. 2002. PMID: 12000194 Clinical Trial.

4

Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.

Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G. Perfetti V, et al. Among authors: merlini g. Blood. 2002 Aug 1;100(3):948-53. doi: 10.1182/blood-2002-01-0114. Blood. 2002. PMID: 12130507 Free article.

5

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril GM, Moratti R, Merlini G. Palladini G, et al. Among authors: merlini g. Circulation. 2003 May 20;107(19):2440-5. doi: 10.1161/01.CIR.0000068314.02595.B2. Epub 2003 Apr 28. Circulation. 2003. PMID: 12719281 Free article. Clinical Trial.

6

Amyloidosis and Waldenström's macroglobulinemia.

Gertz MA, Merlini G, Treon SP. Gertz MA, et al. Among authors: merlini g. Hematology Am Soc Hematol Educ Program. 2004:257-82. doi: 10.1182/asheducation-2004.1.257. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561687 Review.

7

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL).

Palladini G, Perfetti V, Perlini S, Obici L, Lavatelli F, Caccialanza R, Invernizzi R, Comotti B, Merlini G. Palladini G, et al. Among authors: merlini g. Blood. 2005 Apr 1;105(7):2949-51. doi: 10.1182/blood-2004-08-3231. Epub 2004 Nov 30. Blood. 2005. PMID: 15572585 Free article. Clinical Trial.

8

Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis.

Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G, Gertz MA. Palladini G, et al. Among authors: merlini g. Amyloid. 2005 Jun;12(2):120-6. doi: 10.1080/13506120500107055. Amyloid. 2005. PMID: 16011989

9

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Gertz MA, et al. Among authors: merlini g. Am J Hematol. 2005 Aug;79(4):319-28. doi: 10.1002/ajh.20381. Am J Hematol. 2005. PMID: 16044444 Free article. Review.

10

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.

Treon SP, Gertz MA, Dimopoulos M, Anagnostopoulos A, Blade J, Branagan AR, Garcia-Sanz R, Johnson S, Kimby E, Leblond V, Fermand JP, Maloney DG, Merlini G, Morel P, Morra E, Nichols G, Ocio EM, Owen R, Stone MJ. Treon SP, et al. Among authors: merlini g. Blood. 2006 May 1;107(9):3442-6. doi: 10.1182/blood-2005-02-0833. Epub 2006 Jan 12. Blood. 2006. PMID: 16410453 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

615 results

Search Page